Inmaculada Lasa Unzue-rekin lankidetzan egindako argitalpenak (17)

2024

  1. Effect of Tumor Regression Grade on Survival and Disease-Free Interval in Patients Operated on for Locally Advanced Rectal Cancer

    Cancers, Vol. 16, Núm. 10

  2. The Immune Modulation HLA-G*01:01:01 Full Allele Is Associated with Gastric Adenocarcinoma Development

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

2023

  1. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Journal of Clinical Medicine, Vol. 12, Núm. 13

2022

  1. Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer

    Cellular Immunology, Vol. 382

  2. Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO2: A Safe Technique

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  3. Jejunal diverticulitis as an unusual cause of pylephlebitis

    Gastroenterologia y Hepatologia, Vol. 45, pp. 22-23

2021

  1. A reliable and standardizable differential PCR and qPCR methodology assesses HER2 gene amplification in gastric cancer

    Biology, Vol. 10, Núm. 6

  2. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

    The Lancet Oncology, Vol. 22, Núm. 11, pp. 1507-1517

  3. HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients

    Frontiers in Immunology, Vol. 12

  4. Spontaneous rupture of a simple liver cyst: success of a conservative approach

    Revista Argentina de Cirugia(Argentina), Vol. 113, Núm. 4, pp. 482-486

  5. TGFB1 polymorphisms and TGF-β1 plasma levels identify gastric adenocarcinoma patients with lower survival rate and disseminated disease

    Journal of Cellular and Molecular Medicine, Vol. 25, Núm. 2, pp. 774-783

2008

  1. Herpesvirus saimiri transformation may help disclose inherent functional defects of mucosal T lymphocytes in patients with gastric adenocarcinoma

    Immunology and Cell Biology, Vol. 86, Núm. 3, pp. 289-291

2007

  1. FcRγ chain does not replace CD3ζ chain in CD3ζ-deficient T lymphocytes of patients with gastric adenocarcinoma

    Molecular Immunology, Vol. 44, Núm. 9, pp. 2400-2405

2006

  1. Erratum to "Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma" [Cell. Immunol. 238 (2005) 113-122] (DOI:10.1016/j.cellimm.2006.02.007)

    Cellular Immunology

  2. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 55, Núm. 6, pp. 744-748

2005

  1. Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma

    Cellular Immunology, Vol. 238, Núm. 2, pp. 113-122

2003

  1. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 11, pp. 708-714